Skip to main content
. 2019 May 22;86(6):676–686. doi: 10.1016/j.bjorl.2019.04.008

Table 4.

Comparison of the treatment outcomes between groups.

Cisplatin ≥200 mg/m2 Cisplatin <200 mg/m2 Total Cisplatin
Weekly
Cisplatin
3 weekly
Total
n (%) n (%) n (%) p n (%) n (%) n (%) p
Treatment response 0.42
 Partial 14 (17.1) 4 (25) 18 (18.4) 0.48 13 (21.3) 5 (13.5) 18 (18.4)
 Complete 68 (82.9) 12 (75) 80 (81.6) 48 (78.7) 32 (86.5) 80 (81.6)
Local recurrence 0.02
 − 66 (80.5) 9 (56.3) 75 (76.5) 0.03 42 (68.9) 33 (89.2) 75 (76.5)
 + 16 (19.5) 7 (43.7) 23 (23.5) 19 (31.1) 4 (10.8) 23 (23.5)
Regional recurrence 0.25
 − 76 (92.7) 14 (87.5) 90 (91.9) 0.61 54 (88.5) 36 (97.3) 90 (91.8)
 + 6 (7.3) 2 (12.5) 8 (8.1) 7 (11.5) 1 (2.7) 8 (8.2)
Distant metastasis 1.00
 − 69 (84.1) 12 (75) 81 (82.6) 0.46 50 (82) 31 (83.8) 81 (82.7)
 + 13 (15.9) 4 (25) 17 (17.4) 11 (18) 6 (16.2) 17 (17.3)

a Fisher's exact test value.